HGH Fragment 176-191 alternatives.

10 compounds compared to HGH Fragment 176-191, ranked by published evidence tier and regulatory status, not by what's marketed hardest.

Why people look for an alternative

The appeal of HGH Fragment 176-191 is the promise of growth hormone's fat-mobilizing end without its growth-promoting or insulin-antagonizing end. People search for alternatives once they discover the fragment itself has almost no dedicated clinical data, and that its refined cousin AOD-9604 was investigated for obesity and never reached approval as a medicine. That is the honest position: no compound built on this fragment of the GH molecule has cleared a regulator for weight loss. The alternatives that actually carry approvals for weight management work through a completely different mechanism, the incretin pathway, so what you are comparing is not a better version of this idea but a different idea.

What you're comparing against
HGH Fragment 176-191
F tier · 30/100Research / preclinical

HGH Fragment 176-191 is a synthetic peptide corresponding to the final 16 amino acids (residues 176 to 191) of the C-terminal region of human growth hormone.

Ranked by evidence · strongest first
  1. 01
    AOD-9604
    D tierResearch / preclinical

    Acts through the adipose tissue and lipolysis signalling pathway, like HGH Fragment 176-191. Research / preclinical.

  2. 02
    Adipotide
    F tierResearch / preclinical
    FTPP

    Acts through the adipose tissue and lipolysis signalling pathway, like HGH Fragment 176-191. Research / preclinical.

  3. 03
    5-Amino-1MQ
    F tierResearch / preclinical

    Acts through the adipose tissue and lipolysis signalling pathway, like HGH Fragment 176-191. Research / preclinical.

  4. 04
    Semaglutide
    S tierFDA-approved
    Ozempic · Wegovy

    Same category: metabolic & glp-1. FDA-approved.

  5. 05
    Liraglutide
    S tierFDA-approved
    Victoza · Saxenda

    Same category: metabolic & glp-1. FDA-approved.

  6. 06
    Tirzepatide
    S tierFDA-approved
    Mounjaro · Zepbound

    Same category: metabolic & glp-1. FDA-approved.

  7. 07
    Survodutide
    B tierIn human trials
    BI 456906

    Same category: metabolic & glp-1. In human trials.

  8. 08
    Mazdutide
    B tierIn human trials
    IBI362 · LY3305677

    Same category: metabolic & glp-1. In human trials.

  9. 09
    Retatrutide
    B tierIn human trials
    triple agonist

    Same category: metabolic & glp-1. In human trials.

  10. 10
    Cagrilintide
    C tierIn human trials
    amylin analog

    Same category: metabolic & glp-1. In human trials.

How this list is built

An “alternative” here means a compound that shares HGH Fragment 176-191's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.

Comparing options with your provider?

PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page
Compounds